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A Novel Striated Muscle-Specific
Myosin-Blocking Drug for the Study
of Neuromuscular Physiology
Dante J. Heredia, Douglas Schubert, Siddhardha Maligireddy, Grant W. Hennig and
Thomas W. Gould*
Department of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV, USA
The failure to transmit neural action potentials (APs) into muscle APs is referred to
as neuromuscular transmission failure (NTF). Although synaptic dysfunction occurs
in a variety of neuromuscular diseases and impaired neurotransmission contributes
to muscle fatigue, direct evaluation of neurotransmission by measurement of
successfully transduced muscle APs is difficult due to the subsequent movements
produced by muscle. Moreover, the voltage-gated sodium channel inhibitor used
to study neurotransmitter release at the adult neuromuscular junction is ineffective
in embryonic tissue, making it nearly impossible to precisely measure any aspect
of neurotransmission in embryonic lethal mouse mutants. In this study we utilized
3-(N-butylethanimidoyl)-4-hydroxy-2H-chromen-2-one (BHC), previously identified in a
small-molecule screen of skeletal muscle myosin inhibitors, to suppress movements
without affecting membrane currents. In contrast to previously characterized drugs
from this screen such as N-benzyl-p-toluene sulphonamide (BTS), which inhibit skeletal
muscle myosin ATPase activity but also block neurotransmission, BHC selectively
blocked nerve-evoked muscle contraction without affecting neurotransmitter release.
This feature allowed a detailed characterization of neurotransmission in both embryonic
and adult mice. In the presence of BHC, neural APs produced by tonic stimulation of
the phrenic nerve at rates up to 20 Hz were successfully transmitted into muscle APs.
At higher rates of phrenic nerve stimulation, NTF was observed. NTF was intermittent
and characterized by successful muscle APs following failed ones, with the percentage
of successfully transmitted muscle APs diminishing over time. Nerve stimulation rates
that failed to produce NTF in the presence of BHC similarly failed to produce a loss
of peak muscle fiber shortening, which was examined using a novel optical method
of muscle fatigue, or a loss of peak cytosolic calcium transient intensity, examined in
whole populations of muscle cells expressing the genetically-encoded calcium indicator
GCaMP3. Most importantly, BHC allowed for the first time a detailed analysis of synaptic
transmission, calcium signaling and fatigue in embryonic mice, such as in Vamp2mutants
reported here, that die before or at birth. Together, these studies illustrate the wide utility
of BHC in allowing stable measurements of neuromuscular function.
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INTRODUCTION
Impaired synaptic transmission is observed at early stages
of many neurodegenerative and auto-immune diseases of the
central and peripheral nervous systems (Shankar and Walsh,
2009; Milnerwood and Raymond, 2010; Kayser and Dalmau,
2011). For example, at the neuromuscular junction (NMJ),
the peripheral synapse between motor neurons (MNs) and
skeletal muscle, disruption of synaptic transmission leads to
diminished motor function in auto-immune diseases such
as Lambert-Eaton Myasthenic Syndrome (LEMS; Kaja et al.,
2007) and Myasthenia Gravis (MG; Serra et al., 2012) or
inherited ataxias such as episodic ataxia 2 (EA2; Maselli
et al., 2003). Similarly, deterioration of synaptic transmission
occurs in advance of denervation and axon degeneration in
neurodegenerative diseases such as spinal motor atrophy (SMA;
Martinez et al., 2012) and amyotrophic lateral sclerosis (ALS;
Shahidullah et al., 2013). Impaired neurotransmission also is
a feature of muscular dystrophy (MD; van der Pijl et al.,
2016) and inherited peripheral neuropathies such as Charcot-
Marie Tooth disease Types 1 and 2 (CMT1, 2; Yin et al.,
2004; Spaulding et al., 2016) Recently, we observed functional
defects in the absence of denervation in an animal model of
congenital hypomyelinating neuropathy (CHN; Scurry et al.,
2016). Other forms of peripheral neuropathy such as type
2 diabetes also exhibit defective neuromuscular transmission
(Allen et al., 2015). Finally, disruptions of synaptic transmission
contribute to the reduction in muscle force caused by continued
muscle activity, commonly referred to as muscle fatigue (Bazzy
and Donnelly, 1993). Therefore, deciphering the mechanisms of
impaired neuromuscular transmission is an integral component
of therapeutic strategies aimed at restoring neuromuscular
function in disease.
A failure to convert presynaptic neuronal action potentials
(APs) to postsynaptic muscle APs is referred to as neural
transmission failure (NTF). NTF may result from a failure
of the neuronal action potential to propagate down the
axon to presynaptic terminals, a reduction of the release of
neurotransmitter by presynaptic terminals, an impairment of
postsynaptic sensitivity to neurotransmitter, or a disruption
of the propagation of the muscle action potential along the
sarcolemma (Sieck and Prakash, 1995). The mechanisms of
NTF have been explored in studies of high-frequency nerve
stimulation (HFS), which result in synaptic depression caused
by a reduction or rundown in the release of neurotransmitter
(Eccles, 1943; Otsuka et al., 1962). For example, presynaptic
features contributing to synaptic depression include a reduction
in the number of synaptic vesicles released (quantal content)
or in the amount of neurotransmitter per synaptic vesicle
(quantal size; Heuser et al., 1979; Naves and Van der
Kloot, 2001). The reduction of vesicle release underlying
Abbreviations: NMJ, Neuromuscular Junction; MN, Motor neuron; NTF, Neural
Transmission Failure; RRP, Ready Releasable Pool; AP, Action Potential; EPP,
Endplate Potential; mEPP, miniature Endplate Potential; Ach, Acetylcholine;
µ-CTX, µ-conotoxin; BHC, 3-(N-butylethanimidoyl)-4-hydroxy-2H-chromen-
2-one; BTS, N-benzyl-p-toluene sulphonamide; HFS, High-frequency Nerve
Stimulation; MHC, Myosin Heavy Chain; ST, Spatio-temporal.
synaptic depression is caused by the depletion of vesicles in
the ready releasable pool (RRP), a population of synaptic
vesicles docked to the presynaptic membrane and released
first upon nerve stimulation (von Gersdorff and Matthews,
1997).
At the vertebrate NMJ, the electrophysiological measurement
of neurotransmitter (acetylcholine; ACh) release is performed
by the recording of synaptic membrane potential or current in
response to nerve stimulation. This technique is facilitated by
the use of µ-conotoxin IIIb (µ-CTX), which inhibits the skeletal
muscle-specific, voltage-gated Nav1.4 channel and therefore
isolates the ACh receptor-mediated endplate current or potential
(EPC, EPP) from the Nav1.4-mediated action potential (AP;
Hong and Chang, 1989). In addition, this drug paralyzes the
muscle, permitting the electrophysiological study of HFS on
transmitter release by limiting muscle movement. Coupled with
studies of muscle force decline in response to similar paradigms
of high-frequency nerve vs. muscle stimulation, the relative
contribution of NTF to fatigue has been assessed (Kuei et al.,
1990).
Although µ-CTX is a useful tool to measure ACh release
at the vertebrate NMJ, it cannot be used to directly determine
the amount of ACh required to trigger muscle contraction
(i.e., the level needed to avoid NTF), because the threshold
for Nav1.4 channel activation is less than the amount of ACh
released in response to nerve stimulation and measured in the
presence of µ-CTX (Rich, 2006). This discrepancy, referred
to as the safety factor, ensures that modest disruptions of
ACh release fail to prevent neuromuscular signal transmission.
Therefore, in order to assess what level of diminished ACh
release is sufficient to fall below the safety factor and trigger
NTF, the amount released must be measured and compared to
the amount required to open Nav1.4 channels. This threshold
has been measured by comparing muscle potential waveforms
elicited by nerve stimulation in the presence of paralytic vs.
sub-paralytic doses of the ACh receptor-binding toxin curare
(Wood and Slater, 2001). Whereas sub-maximal, paralytic curare
doses exclusively produce an EPP waveform, subparalytic doses
produce a compound waveform of the EPP and the AP, and the
point of AP inflection represents the Nav1.4 activation threshold.
Using these approaches, the safety factor in rodent diaphragm has
been estimated as 1.7–5, suggesting that NTF emerges when EPP
amplitudes fall to as little as 58% of their original values (Wood
and Slater, 2001).
Measuring NTF in this fashion is indirect, technically difficult
and also produces movement, fracturing electrodes. Moreover,
because Nav1.4 channels are blocked, the parameters of the
unattenuated muscle AP itself cannot be assessed in response
to nerve stimulation. Although muscle stimulation-evoked APs
have been measured in teased fiber bundles that are physically
manipulated to prevent movement (Delbono and Kotsias, 1987),
or in response to single nerve-evoked APs (van Lunteren
and Moyer, 1998), this approach has limited utility in the
study of neuromuscular function. Because a wide variety of
cell-specific gene overexpression or deletion models, as well
as neurodegenerative and auto-immune disease models, are
available in mice, the ability to inhibit contractility for the
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evaluation of APs in this animal model would be a powerful
tool to elucidate the molecular mechanisms of NTF. With such
a tool, NTF could be directly measured as failed muscle APs,
whose height would be dramatically less than successful APs,
based on the all-or-nothing nature of the muscle AP. Moreover,
the study of factors affecting AP waveform parameters could
be easily investigated. Muscle calcium dynamics could also be
evaluated in response to nerve stimulation with such a drug,
in contrast to studies using µ-CTX, because movement but
not the release of calcium from intracellular stores would be
blocked. Finally, the analysis of neurotransmission in embryonic
mouse mutants could be assessed for the first time, since
Nav1.5 channels, which are resistant to µ-CTX (Wilson et al.,
2011), are expressed in fetal muscle, rather than µ-CTX-
sensitive Nav1.4 channels (Lupa et al., 1993). Recently, a drug
originally identified in a skeletal muscle-specific myosin ATPase-
inhibitor screen, N-benzyl-p-toluene sulfonamide (BTS; Cheung
et al., 2002), was used to measure muscle APs and ionic
currents in adult mouse skeletal muscle cells Wang et al., 1999;
Woods et al., 2004), as well as to measure nerve stimulation-
induced muscle APs at the cane toad NMJ (Etherington et al.,
2014).
In order to determine if BTS or other small molecules
could inhibit skeletal muscle movement without affecting
neurotransmission in mice tissue, we examined their effect
in hemidiaphragm preparations. We show that although
BTS is unable to inhibit mouse diaphragm contractility
without also inhibiting phrenic nerve-induced release of
ACh, a second drug identified but not characterized in the
myosin ATPase screen, 3-(N-butylethanimidoyl)-4-hydroxy-2H-
chromen-2-one (heretofore referred to as BHC), effectively
blocks muscle movement without affecting nerve function. First,
we characterize the effects of BHC on nerve-evoked APs. We
then utilize BHC to compare the relative time to predicted
AP failure (in the presence of µ-CTX) to the actual time
of AP failure (NTF; in the presence of BHC) in response to
HFS. Next, we compare the rates of HFS that cause NTF
with those that cause muscle fatigue, using conventional and
novel methods to measure muscle force. Using transgenic
mice expressing GCaMP3, we then employ BHC to examine
the effects of HFS on calcium signaling in muscle fibers.
GCaMP3 is a fusion protein between the cytosolic calcium-
sensing protein calmodulin and the fluorescent reporter GFP
(Tian et al., 2009). In the absence of calcium, the fluorescence
of GCaMP3 is inhibited, whereas in response to an increase
of cytosolic calcium, a conformational shift occurs, and the
protein fluoresces, producing a calcium transient. Finally, we
demonstrate that BHC blocks muscle movement in response
to nerve stimulation during embryonic development, allowing
for the measurement of nerve stimulation-induced muscle
APs and calcium signaling. Using BHC, we show that NTF
occurs prematurely and fatigue is enhanced in synaptobrevin
2/Vamp2 mutants, which die immediately after birth. Together,
these studies introduce BHC as an experimental tool that
permits the study of multiple new features of neuromuscular
transmission during embryogenesis and in the context of
disease.
MATERIALS AND METHODS
Ethical Approval and Use of Mice
Animal husbandry and experiments were performed in
accordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals and the Institutional
Animal Use and Care Committee at the University of Nevada.
Vamp2mutant mice were purchased from Jax. CAGGS-GCaMP3
transgenic mice were kindly provided by S. Pfaff (Salk Institute,
San Diego, CA, USA). Each of these mice was backcrossed
several times into the Balb/C background. For studies with
adults, control Balb/C mice were sacrificed at 3–4 months of age.
For studies of embryos, females were timed bred with males, and
noon on the day of the plug was designated E0.5. After cervical
dislocation of the dam, embryos were quickly dissected with
their placentas intact and placed in oxygenated (95% O2 and 5%
CO2) Krebs-Ringer’s solution, tails were cut and processed for
genotyping (e.g., Vamp2 mutants) by incubating in 100 µl of 10
N NaOH / 0.2 mM EDTA at 100 degrees for 15 min, followed
by neutralization with 100 µl of 40 mM Tris, pH 5, and diluted
10-fold in water before being used as a template for PCR. During
the PCR, diaphragms from every littermate were dissected and
placed in changes of freshly oxygenated Krebs-Ringer’s solution
every 30 min.
Drugs
BHC (Catalog number 5102862; Hit2Lead/Chembridge, San
Diego, CA, USA) was dissolved in DMSO at 100 mM and
frozen in aliquots at −20. Four µl of this stock was then
added to 16 µl of DMSO, which was then bath applied
to a Sylgard-coated 6-ml dish containing 8 mls of Krebs-
Ringer’s solution for 30 min without perfusion. This resulted
in concentrations of 50 µM BHC and 0.05% DMSO. The bath
was then perfused for 30 min before recording or imaging
experiments commenced. BTS (TCI Chemicals, Portland, OR,
USA) was dissolved in DMSO and used at the concentrations
indicated. The Nav1.4 antagonist µ-conotoxin GIIIb (µ-CTX;
Peptides International, Louisville, KY, USA) was dissolved in
water and used at a final concentration of 2.3 µM. Finally, 3-
(N-butylethanimidoyl)-4-hydroxy-2H-chromen-2-one (Catalog
number 5102863; Hit2Lead/Chembridge) was used at 50 µM in
similar fashion to BHC.
Myosin Heavy Chain
Immunohistochemistry
The central region of the costal portion of the left diaphragm
muscle was dissected from adult mice that had been anesthetized
with isoflurane. The tissue was then rinsed in PBS and
immediately fresh-frozen in a cryomold containingOCT (Tissue-
Tek, Sakura, CA) in 2-methylbutane on dry ice. The tissue was
cut transversely at 16 µm and immediately immersed in IgG
blocking reagent (1/100 in PBS) for 30 min at room temperature
(RT; 21◦C) and then protein diluent (1/100 in PBS) for 30
min at RT, both from the mouse-on-mouse (MOM) kit (Vector
Labs, Burlingame, CA, USA). Mouse primary antibodies (BA-
F8 against myosin heavy chain (MHC) Type I; SC-71 against
MHC Type IIA, and BF-F3 against Type IIB) were added at
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1/100 concentration into protein diluent solution overnight at
four degrees, rinsed then incubated with mouse isotype-specific
fluorescent secondary antibodies as described (Bloemberg and
Quadrilatero, 2012). We were unable to produce staining with
the 6H1 antibody against Type IIX-expressing fibers, but utilized
the slight background obtained with Type IIB staining to identify
and count negative cells as Type IIX.
Electrophysiology
Whole diaphragm muscles were dissected and pinned on
a Sylgard-coated dish containing oxygenated Krebs-Ringer’s
solution at RT as described (Scurry et al., 2016). After 30
min of perfusion, the left phrenic nerve was drawn into a
suction electrode and stimulated with supra-maximal square
waves from an SD9 stimulator (2–5 V, 0.1 ms for adults;
4–10 V, 0.1 ms for embryos) or from an S48 stimulator
coupled to a SIU5 stimulus isolation unit (both from Grass,
Quincy, MA, USA). Sharp intracellular recording electrodes
were made with tip resistances of ∼30–60 M and backfilled
with 2 M potassium citrate and 10 mM potassium chloride.
Correct positioning of micro-electrodes at the motor endplate
of the costal diaphragm was confirmed at the beginning of an
experiment by electrophysiological measures (i.e., rise-to-peak or
10–90% rise times of miniature endplate potentials (mEPPs) <2
ms) as well as by post-hoc fluorescently-labeled α-bungarotoxin
labeling. Muscle action potentials (APs) were recorded after
treatment with 50 µM BHC for 30 min, followed by 30 min of
washing. EPPs were recorded after treatment with 2.3 µM µ-
CTX. Signals were amplified using an Axoclamp 900A amplifier,
digitized at 2 KHz using a Digidata 1550 and recorded using
Axoscope software before being analyzed with the Clampfit data
analysis module within pCLAMP10 software (Molecular Devices,
Sunnyvale, CA, USA). mEPP, EPP, and AP decay times were
calculated by measuring the descent time from peak to half
amplitude, and halfwidths were calculated by measuring the time
between half-maximal amplitudes on upslope and downslope.
Only muscle fibers with resting membrane potentials between
−60 and −75 mV were included for analysis. Tonic stimulation
episodes of the phrenic nerve over 10 Hz were separated by 30-
min rest periods to allow recovery. In order to calculate percent
failure (APs) or percent transmitter release rundown (EPPs), the
average of three potentials at each second of the 30-s train was
taken and expressed as a percent of the first three potentials.
For comparisons of APs to EPPs in response to 100 Hz (e.g.,
Figure 2E), the electrode was left in the same cell in between BHC
and µ-CTX treatment. This experiment therefore produced only
one recording in each drug per animal, and was performed four
times with the same results.
Tension Recording of Specific Force
Longitudinal strips of diaphragm muscle containing the phrenic
nerve were isolated by making two lateral cuts from the central
tendon to the thoracic wall ∼2–4 mm apart. The preparation
was secured to the bottom of a Sylgard-lined dish using two
sutures from the rib cage looping to hooks on the dish. A
single fiber of braided suture silk (6–0, Ethicon, Sommerville,
NJ, USA) was fastened around the central tendon and attached
to a force transducer and amplifier (Transbridge 4 M, WPI,
Sarasota, FL, USA). A suction electrode was attached to the
phrenic nerve to provide suprathreshold nerve stimulation at 1,
10, 20, 40, and 100 Hz. Optimal muscle length and stimulation
voltage were determined from micromanipulation of muscle
length to produce peak force. Contractile activity was digitized
using a Digidata 1332A recorded on a PC running Axoscope
10 (Molecular Devices). After contractile recordings, the muscle
strip was trimmed from the tendon and rib cage, blotted on a Kim
wipe and weighed on an analytical balance. Specific force was
calculated by dividing recorded force (mN) by the Cross Sectional
Area, where CSA, in mm2, = strip mass in mg/[(optimal muscle
length in mm)∗(L/Lo)∗(1.06 mg/mm3)]. L/Lo is the fiber to
muscle length ratio (1.0 for diaphragm; Brooks and Faulkner,
1988).
Optical Recording of Fiber Shortening
Brightfield and fluorescence recordings were performed on a
Nikon Eclipse FN1 upright microscope using Nikon Plan Fluor
4x and 10x lenses (Nikon, USA). Image sequences were captured
using an Andor Neo (Andor Technology, Belfast, UK) sCMOS
camera and transferred to aWindows-based PC using Nikon NIS
Elements 4.1 (Nikon, USA). Image sequences were recorded at 25
frames per second, processed as 8-bit intensity units, converted
to multipage TIFF files and imported into and analyzed by
custom software (Volumetry G8d; GWH;Hennig et al., 2002). To
measure contraction (fiber shortening) from brightfield movies,
two contrasted regions were identified. In most situations,
these were blood vessels. To enhance the signal:noise ratio of
the tracking regions, spatio-temporal maps (ST maps) were
constructed with the axis of averaging perpendicular to the long
axis of the muscle fibers (e.g., Figure 5A). After thresholding, the
movement of the two regions was tracked in the ST maps using
edge detection, and the distance was then calculated between
them. In this manner, the shortening between the regions
could be calculated regardless of the overall displacement of the
diaphragm during stimulation.
Calcium Imaging
The diaphragm of CAGGS-GCaMP3 mice was excited at 470 nm
by a Lumencor Spectra X light engine (Lumencor, Beaverton,
Oregon, USA). Image sequences were captured, recorded and
analyzed as described above. In order to calculate maximal
fluorescence (Fmax) exhibited by GCaMP3 in skeletal muscle,
0.5 M potassium chloride (KCl) was added to diaphragm
preparations, as larger fluorescences were not observed in
response to treatment with ionomycin (to allow influx of
extracellular calcium) or to the RyR agonist caffeine or the
SERCA antagonist cyclopiazonic acid (to deplete sarcoplasmic
reticular calcium stores). First, the optimal dynamic range of
the camera sensor was established in response to KCl. Although
the Andor Neo cMOS chip sensor reportedly exhibits saturation
in 16-bit mode at 65,000 counts (2e16), by pseudocoloring
pixel saturation, GCaMP3-expressing muscle tissue exhibited
saturation at 20X magnification and 3 × 3 binning when the
brightness bar on the lookup table was moved to the left of
2000 counts. Therefore, all nerve stimulation experiments were
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carried out with this bar set to 110% of this level, or ∼2200
counts. When nerve stimulation experiments were performed
in this context, the largest fluorescence (the initial peak in
response to 20–100 Hz stimulation), was never higher than
500 counts, confirming that neither the camera sensor nor the
biosensor were saturated. A number of spatio-temporal maps (ST
maps) were used to portray and analyze the pattern of calcium
transients in muscle cells in response to nerve stimulation.
The main type was the standard deviation map, which was
generated by calculating the standard deviation of fluorescence
intensity at every pixel immediately prior to the application
of the stimulus (0.5–1.0 s) extending to 30–50 s depending on
the stimulus used. Standard deviations were color coded (“Fire”
CLUT) to more accurately portray the relative intensity of the
signal in muscle cells in relation to background noise (Hennig
et al., 2015). To better appreciate the heterogeneity of muscle
fiber responses during different stimulation paradigms, ST maps
were colored and overlaid and summary images were created
using different statistical procedures including average intensity
and the standard deviation of intensity (e.g., Figures 6B,C).
The change in intensity was referenced to baseline or maximal
intensity (typically 1 s after phrenic nerve stimulation).
Statistics
All data were expressed as means± SD Student’s t-tests assuming
equal variance, with or without the Bonferroni correction, were
used to assess differences between two samples. A P < 0.05 was
considered significant.
RESULTS
Electrophysiological Characterization of
the Effect of BTS As Well As the
Hydroxycoumarin Derivative, BHC, on
Muscle Responses to Nerve Stimulation
The effect of BTS on nerve-evoked adult mouse diaphragm
contractions was first examined. Treatment with 1µMBTS failed
to reduce nerve stimulation-induced muscle contractions, but
5 µM BTS completely inhibited them to a point at which they
were unresolvable in bright-field videos (data not shown). At
this concentration, muscle action potentials (APs) in response to
nerve stimulation were much smaller than expected (10–20 mV
vs. 70–90 mV; van Lunteren and Moyer, 1998; n = 5 from three
mice; data not shown). At higher doses of BTS, such as those used
in previous studies of the toad NMJ (50 µM; Etherington et al.,
2014), nerve-evoked muscle potentials decreased below 5 mV (n
= 5 from three mice; Supplementary Figure 1).
The effects on nerve-evoked muscle contraction
of the two hydroxycoumarin derivatives that also
blocked myosin ATPase activity in purified muscle cells
(BHC and 3-(N-butylethanimidoyl)-4-hydroxy-6-nitro-2H-
chromen-2-one; Cheung et al., 2002) were then assessed. Only
BHC reduced muscle contractile responses to a level that was
unresolvable (data not shown). At a dose of 10 µM, BHC
partially blocked muscle contractions, but at 50 µM, BHC
reduced diaphragm muscle movement to a level that was
unresolvable across a wide range of phrenic nerve stimulation
frequencies (see below, Figure 2). Complete paralysis was
maintained for over 3 h after washout before movement
gradually returned (n= 3 from three mice; data not shown).
In contrast to BTS, BHC treatment failed to attenuate the
size of nerve-evoked muscle APs, which exhibited parameters
similar to published estimates obtained in response to single
pulses of direct muscle stimulation of adult rat diaphragm (Adult
AP amplitude = 75.3 ± 2.2 mV; n = 55 from 10 mice; vs.
75.6 ± 3.2 mV; Delbono and Kotsias, 1987). To determine the
effects of age, nerve-evoked muscle APs were recorded from
diaphragm muscle derived from embryonic day 15.5 (E15.5),
postnatal day 0 (P0) and P5 as well as adult mice. APs were
lower in amplitude and longer in duration during embryonic
periods but became significantly larger and shorter in duration
immediately after birth (Figures 1A–F). Finally, to test whether
BHC exerted effects on neuromuscular physiology other than
blocking contractility, resting membrane potential, miniature
endplate potential (mEPP) frequency and amplitude, and EPP
amplitude were all measured in the presence or absence of
BHC (Figures 1G–J). No significant differences in any of these
measures were observed, suggesting that BHC does not affect the
ion dynamics underlying muscle APs.
Neural Transmission Failure (NTF) in
Response to High-Frequency Nerve
Stimulation
High-frequency nerve stimulation (HFS) was used to induce
neurotransmission failure in the adult mouse diaphragm.
Although phrenic MNs discharge phasically (e.g., duty cycle of
0.33) during respiration, they also produce tonic contraction
of the diaphragm to elevate intra-abdominal pressure during
expulsive maneuvers such as vomiting, coughing or defecation,
to aid in postural control during upper limb movement (Hodges
and Gandevia, 2000), or to maintain head-level arterial pressure
during the production of anti-gravity straining maneuvers by
military pilots (Bain et al., 1997). Tonic stimulation of the phrenic
nerve also results in accelerated depletion of neurotransmitter
compared to phasic activation (Moyer and van Lunteren, 1999),
facilitating the study of fatigue. At tonic frequencies <40 Hz,
muscle APs were reliably obtained in response to every pulse
of nerve stimulation for up to 30 s (Figures 2A,B). At 40 Hz,
nerve stimulations failed to produce muscle APs between 20
and 30 s (Figures 2A,B). At 100 Hz, these failures were first
observed toward the end of the initial second of stimulation,
with the percentage of failed muscle APs increasing dramatically
over time (Figures 2A,B). Muscle fiber response to 100 Hz nerve
stimulation could be grouped into one of three subtypes: those
completely failing to produce nerve-evoked muscle APs after
10–15 s, those completely failing to generate APs after 20 s,
and those exhibiting intermittent but not complete AP failure
(Figures 3A,B). The proportion of muscle fibers in each failure
category was then correlated to the proportion of different fiber
subtypes based on MHC isoform composition, which defines
these subtypes according to fatiguability. The relative percentage
of muscle fibers displaying complete transmission failure most
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FIGURE 1 | BHC permits the measurement of nerve-evoked muscle action potentials (APs). (A) Representative image of an AP recorded in the presence of
50µM BHC with a sharp intracellular electrode from the motor endplate of an adult mouse diaphragm muscle fiber in response to a single suprathreshold square
wave phrenic nerve impulse. Note overshoot. Average amplitudes are lower (E15.5 AP amp = 65.5 ± 1.6 vs. adult AP amp = 75.3 ± 2.2 mV; P < 0.001; n = 55 from
10 mice; B), and 10–90% rise-to-peak (E15.5 R2P = 2.7 ± 0.7 vs. adult R2P = 1.6 ± 0.2 ms; P < 0.001; n = 55 from 10 mice; C), 100–50% decay (E15.5 T2D =
37.8 ± 1.6 vs. adult T2D = 2.4 ± 0.2 ms; P < 0.001; n = 55 from 10 mice; D), and 50–50% halfwidth (E15.5 HW = 30.2 ± 2.7 vs. adult HW = 1.2 ± 0.1 ms; P <
0.001; n = 55 from 10 mice; E) of muscle APs are significantly longer at E15.5 (E15.5) than postnatal stages. (F) Average resting membrane potential (RMP) is less
negative at E15.5 vs. postnatal ages (E15.5 RMP = −64.8 ± 4.3 vs. adult RMP = −70 ± 2.6 mV; P < 0.05; n = 5 from three mice; F). The RMP is similar in the
presence or absence of 10 µm BHC in the adult; (−72.4 ± 2.3 vs. −72.2 ± 3.6 mV; P = 0.46; n = 5 from three mice; G). The frequency of miniature endplate
potentials (mEPPs; 0.27 ± 0.04 vs. 0.38 ± 0.03 mEPPs/s; P = 0.06; 10 s analyzed; n = 8 from five mice; H), as well as the amplitude of mEPPs (1.6 ± 0.3 vs. 1.5 ±
0.2 mV; P = 0.1; n = 22 from five mice; I) and EPPs (26.2 ± 1.1 vs. 26.7 ± 1.3 mV; P = 0.06; n = 22 from five mice; J) are similar in the presence or absence of BHC
in the adult. All values expressed in means ±SD.
quickly (18 ± 5.2%, n = 15 from seven mice) was similar to that
exhibiting immunoreactivity to theMHC subtype associated with
fast-fatiguable, glycolytic Type IIB muscle fibers (13.0 ± 2.3%; n
= 10 from three mice; Figure 3C). Similarly, the percentage of
fibers exhibiting failure slightly later (66.3 ± 12.1%; n = 15 from
seven mice) was similar to that exhibiting expression of MHC
Type IIA and Type IIX fast fatigue-resistant, oxidative/glycolytic
myosin (71.4 ± 4.0%; n = 10 from three mice). Finally, the
percentage of fibers exhibiting intermittent APs even after 30 s of
100 Hz nerve stimulation (15.7± 0.7%; n= 15 from seven mice)
was similar to that expressingMHCType I slow oxidative myosin
(13.5 ± 2.7%; n = 10 from three mice). The relative percentages
of these MHC-immunoreactive muscle fiber subtypes in the
adult mouse diaphragm were similar to those of previous reports
(Agbulut et al., 2003; Fajardo et al., 2016). Together, these results
show that BHC permits the direct measurement of NTF at the
vertebrate NMJ.
In order to examine if reduced acetylcholine (ACh) release
contributed to NTF, intracellular muscle fiber potentials were
recorded in response to the same series of frequencies of phrenic
nerve stimulation in the presence of µ-CTX, which blocks
Nav1.4 channels and thus permits the measurement of the ACh-
mediated EPP. The synaptic rundown of ACh release, measured
as EPP amplitudes, was then correlated to muscle AP failure
rates. Stimulation at 1, 10, and 20 Hz generated a modest and
progressive reduction of EPP amplitude after 30 s of stimulation,
with the majority of this decrease occurring in the first second,
whereas 40 and 100 Hz stimulation produced this initial decrease
followed by an additional prolonged reduction of EPP height
(Figures 2A,C). The change from initial to final EPP amplitude
of 28.0 ± 3.87 mV to 23.4 ± 3.58 mV (n = 8 from four mice)
after 30 s of stimulation at 20 Hz in the presence of µ-CTX
is insufficient to cause NTF, because 20 Hz stimulation in the
presence of BHC resulted in 100% successful APs. These results
are consistent with the lowest previously reported safety factor
in rat diaphragm muscle, 1.7, which would require a drop in
EPP amplitude from 28 to 17.6 mV before causing NTF failure
(Wareham et al., 1994). In contrast, the change of initial to final
EPP amplitude in response to 30 s of 40 Hz stimulation (28.0 ±
1.39 mV to 16.2 ± 0.82 mV; n = 9 from four mice) is below
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 December 2016 | Volume 10 | Article 276
Heredia et al. Myosin Blocker to Study Neurotransmission
FIGURE 2 | Comparison of EPPs vs. muscle APs in whole diaphragm in response to high-frequency nerve stimulation (HFS) shows that muscle APs
fail intermittently, whereas neurotransmitter release falls gradually. (A) Left panels show representative muscle AP traces, recorded in the presence of 50 µM
BHC, in response to 30-s trains of tonic phrenic nerve stimulation at different frequencies. Overshoots are portions of the muscle AP above 0 mV, which is demarcated
by a blue line in each trace. Right panels show representative EPP traces, recorded in the presence of 2.3 µM µ-CTX, in response to the same stimuli. Note the
presence of muscle AP failure in response to 100 Hz. (B) The percent of successfully transmitted muscle APs per second (AP %), over time, in response to different
frequencies of HFS (blue = 1 Hz; red = 10 Hz; green = 20 Hz; purple = 40 Hz; light blue = 100 Hz. The straight line at 100% for 1, 10, and 20 Hz reflects the lack of
failure in response to 30 s of stimulation at these frequencies. (C) Synaptic rundown of released neurotransmitter (NT), measured by EPP amplitude, in response to the
same trains of stimuli. (D) Comparison of NT release rundown (in presence of µ-CTX) and neural transmission failure (NTF) in presence of BHC. (E) Left panel shows a
comparison of the first few seconds of AP (BHC) and EPP (µ-CTX) traces in response to 100 Hz stimulation. Asterisk represents first failed AP. Underlined areas are
enlarged in right panel and show the pattern of APs and EPPs after a corresponding period of HFS. For every muscle AP, there are two, nearly equal-sized EPPs.
this estimate of the safety factor (1.73-fold reduction), consistent
with the observation of a small percentage of failed muscle
APs in response to 40 Hz nerve stimulation in the presence
of BHC.
Although a 1.7-fold reduction of EPP amplitude resulted in
NTF in response to 40 Hz stimulation, it does not produce
complete NTF. Rather, only a small percentage of neural APs
failed to produce muscle APs as EPP amplitude fell below
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FIGURE 3 | The percentage of muscle APs with defined times to neural transmission failure coincides with the percentage of muscle fibers expressing
fatigue-conferring myosin isoforms. (A) Representative trace of a muscle fiber exhibiting only intermittent failure for the entire 30-s period in response to 100 Hz
stimulation. Note the difference between this cell and that in Figure 2A. (B) When cells were plotted individually according to when they exhibited NTF, three
subpopulations emerged, those exhibiting failure near 10 s (blue), those near 20 s (green), and those only displaying partial failure even after 30 s, similar to the trace in
(A); (blue line). (C) Fresh-frozen cross sections of muscle stained with antibodies recognizing Type I, slow, oxidative MHC (blue), Type IIA fast fatigue-resistant,
glycolytic/oxidative MHC (green), and Type IIB fast-fatiguable glycolytic MHC (red), or no antibody labeling (Type IIx). Scalebar = 100 µm. The relative percentage of
these myosin-expressing subpopulations is similar to the relative percentage of muscle subpopulations fatiguing in response to 100 Hz at different times, as shown
in (B).
this threshold. In order to investigate this further, EPPs and
APs were examined in response to 100 Hz stimulation, which
produced complete NTF in some muscle fibers (Figure 2A).
The relative percentage of successfully transmitted APs changed
over time. Initially, failed muscle APs occurred within the first
second. In the next 4–5 s, every other muscle AP failed. During
this time, EPPs not only did not fall below the safety factor,
they failed to change significantly in amplitude in an every-
other pattern (Figures 2D,E). Between 10 and 15 s after the
onset of 100 Hz stimulation, there was a marked decrease in
the percentage of successfully transmitted muscle APs. This
decline is correlated with the reduction of EPP amplitudes
below the safety factor. Finally, after 15 s, the percentage
of successful muscle APs dropped again, coinciding with a
further reduction of EPP amplitudes. Together, these results
provide evidence that although percentage rates of NTF are
largely correlated to levels of neurotransmitter release rundown,
impairments of neurotransmission occur intermittently, and
in some cases, independently of reduced neurotransmitter
release.
Relationship of NTF to Muscle Fatigue
(Isolated Strips)
In order to assess the effects of NTF on muscle fatigue, tension
produced by 1–100 Hz phrenic nerve stimulation was measured
in isolated diaphragm strips. Muscle fatigue, or the reduction
of muscle force that occurs in response to repeated stimulation,
is potentially caused by a variety of mechanisms affecting the
central drive to MNs, neurotransmission, and the response of
the muscle fiber to neurotransmission (Sieck and Prakash, 1995).
A 330 ms pulse of 70 Hz stimulation, which produces a fused
tetanus, elicited a specific force of 136.9 ± 12.2 mN/mm2 (n = 3
from three mice; Figure 4A), similar to previous reports (Fajardo
et al., 2016). Continued phasic stimulation of the phrenic nerve at
this frequency (duty cycle 0.33) produced fatigue (72± 3 stimuli
to achieve 60% peak force, which was achieved on the second 330
ms stimulus).
In order to measure the effect of tonic nerve stimulation
frequency on muscle fatigue, the difference between ending and
peak forces wasmeasured. In response to 1Hz for 30 s, which fails
to produce NTF, specific force was unchanged (peak vs. ending
forces of 59.6 ± 4.2 vs. 60.3 ± 3.3 mN/mm2, P = 0.39; n = 3
from three mice; Figure 4B). However, in response to 10 and 20
Hz, which also fails to produce NTF, after a several-second rise
to peak tension, the force declined considerably (10 Hz; peak vs.
ending forces of 83.2± 7.7 vs. 33.2± 3.6 mN/mm2; 60% decline;
P < 0.05; n = 6 from three mice; 20 Hz; peak vs. ending forces
of 110.2 ± 9.3 vs. 57.2 ± 6.1 mN/mm2; 48% decline; P < 0.05;
n = 6 from three mice; Figures 4B–D). At higher frequencies
that caused NTF, further reductions of tension were observed
(40 Hz; peak vs. ending forces of 114.2 ± 14.2 vs. 50.6 ± 16.6
mN/mm2; 56% decline; P < 0.005; n = 3 from three mice; 100
Hz; peak vs. ending forces of 98.4± 17.4 vs. 24.5± 6.1 mN/mm2;
75% decline; P < 0.005; n = 3 from three mice; Figure 4C).
Total force, measured as the area under the 30-s curve (AUC),
was 1762 ± 145 mN/mm2.s in response to 10 Hz, reached its
maximum at 20 Hz (2379 ± 176 mN/mm2.s), was unchanged at
40 Hz (2238 ± 107 mN/mm2.s), and declined at 100 Hz (1650
± 181 mN/mm2.s; n = 3 from three mice). Therefore, despite
the observation that neither 10 Hz nor 20 Hz nerve stimulation
produce NTF, muscle fatigue is observed, suggesting that fatigue
in response to these frequencies of HFS is mediated by factors
downstream of neurotransmission.
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FIGURE 4 | Tension studies in diaphragm strips show fatigue in response to frequencies of nerve stimulation that fail to show neural transmission
failure. (A) Diaphragm strips with intact phrenic nerve were excited with single suprathreshold square wave nerve pulses (twitch) or 330 ms of nerve stimulation at 70
Hz (tetanus). (B) Representative traces of diaphragm strip responses to 30 s trains of tonic nerve stimulation at different frequencies. Note the several-second buildup
to peak tension in response to 10 Hz stimulation, followed by fatigue, as well as the progressively enhanced fatigue in response to 20, 40, and 100 Hz stimulation. (C)
The percent specific force (Force %), over time, in response to different frequencies of HFS, shows that all frequencies above 1 Hz produce fatigue. Error bars left off
for clarity. (D) Comparison of force to AP success rate in response to 10 and 20 Hz shows that peak tension declines in the absence of NTF at these frequencies.
Relationship of NTF to Muscle Fatigue
(Intact Diaphragm)
Because electrophysiological measurements were obtained in
whole diaphragms, whereas those of tension were produced
from diaphragm muscle strips, the comparison between data
generated by these techniques may not be completely valid. For
example, force decline in strips may be enhanced by the absence
of forces acting transversely against the length of the muscle
fiber (Margulies et al., 1994). To better match muscle responses
and electrophysiological measurements, muscle shortening was
measured optically between two fixed regions in response to
nerve stimulation in bright-field videos of whole diaphragms;
(Figure 5A; Video 1). The maximal rising slope of fiber
shortening increased proportionally with nerve stimulation
frequency (3668± 1166 µm/s for 40 Hz vs. 5610± 999 µm/s for
100 Hz; P < 0.05, n = 3 from three mice; for example; compare
rising slopes in merged image in Figure 5B). Similar to results
of tension studies, the highest total shortening (AUC) obtained
by optical methods was observed in response to 20 Hz nerve
stimulation, followed by 40 Hz and then 100 Hz stimulation (1
Hz = 531 ± 52 µm.s; 10 Hz = 3386 ± 278 µm.s; 20 Hz = 8835
± 1176 µm.s; 40 Hz = 7485 ± 624 µm.s; 100 Hz = 4928 ± 762
µm.s; n = 3 from three mice). To assess fatigue, the difference
between peak and length at the end of stimulation (ending
length) was measured. Similar to that measured by tension
recording, muscle shorteningmeasured by optical methods failed
to exhibit fatigue in response to 1 Hz stimulation (peak vs. ending
length changes of 96.5 ± 6.8 µm vs. 102.7 ± 11.3 µm; P =
0.102; n = 4 from three mice; Figure 5B). However, in contrast
to tension measurements with diaphragm strips, this technique
revealed that 10 Hz nerve stimulation failed to cause fatigue in
whole diaphragms. In fact, ending length was essentially equal to
peak length (156.3 ± 26 µm). Interestingly, whereas diaphragm
strips failed to exhibit fusion of muscle twitches into tetanus in
response to 10 Hz nerve stimulation, whole diaphragmmeasured
optically exhibited a transition from twitch to tetanus in response
to 10 Hz (Figures 4B, 5B). Similarly, although the peak length
change induced by 20Hz nerve stimulation appeared unable to be
maintained, this difference was not statistically significant (peak
vs. ending length changes after 20 Hz were 339.6± 34.3 vs. 293.2
± 42.1 µm; P = 0.053; n = 4 from three mice). In contrast,
40 and 100 Hz nerve stimulation produced fatigue (Figure 5B).
However, in both cases, similar to the effects of 10 and 20 Hz
nerve stimulation, fatigue produced by 40 and 100Hz stimulation
was smaller with optical vs. tension measurements. For example,
peak vs. ending length changes after 40 Hz were 335.8 ± 83.8 vs.
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FIGURE 5 | Fiber shortening studies in whole diaphragm fail to show
fatigue in response to frequencies of nerve stimulation that fail to
show neural transmission failure. (A) Field of view from which optical
measurements were taken and distance between the two contrasted regions
(indicated by red, blue bars) that were tracked in response to nerve
stimulation. (B) Representative percent control traces of fiber shortening in
response to different frequencies of tonic nerve stimulation. Note the change
to tetanus in response to 10 Hz. Note also the lack of fatigue in response to 10
and 20 Hz stimulation, in contrast to tension studies. (C) Comparison of force
to AP success rate in response to 10 and 20 Hz shows that peak fiber
shortening does not decline in the absence of NTF at these frequencies.
214 ± 56.9 µm; P < 0.05; n = 4 from three mice (36.1 vs. 56%);
and after 100 Hz were 239.3± 31.7 vs. 114± 23.2µm; P< 0.005;
n = 4 from three mice (52.3 vs. 75%). Therefore, in contrast to
tension recording of diaphragm strips, optical recording of fiber
shortening in whole diaphragms fails to show fatigue in response
to 10 and 20 Hz nerve stimulation (Figure 5C).
Relationship of NTF, Muscle Fatigue, and
Cytosolic Calcium Levels
Calcium release from the sarcoplasmic reticulum into the cytosol
transduces the nerve-induced muscle AP into a contractile
response. Fatiguing tetanic stimulation of isolated muscle fibers
causes a reduction of calcium release (Allen et al., 2008). In order
to determine whether calcium release was differentially affected
in response to muscle fatigue-inducing nerve stimulation,
whole diaphragms of transgenic mice expressing the genetically
encoded calcium indicator GCaMP3 (CAGGS-GCaMP3) were
treated with BHC to block movement and imaged in response
to 30-s trains of phrenic nerve stimulation. Similar to the
production of muscle APs, 1 Hz nerve stimulation reliably
produced calcium transients for 30 s (Figure 6A). Similar to
fiber shortening, the maximal rising slope of calcium-induced
fluorescence increased proportionally with nerve stimulation
frequency (compare in merged image in Figure 6A). Also similar
to fiber shortening, the highest total transient intensity (AUC)
was observed in response to 20 Hz nerve stimulation, followed
by 40 Hz stimulation (1 Hz = 2527 ± 721 iu16.s; 10 Hz =
4108 ± 1230 iu16.s; 20 Hz = 4258 ± 640 iu16.s; 40 Hz = 4214
± 1327 iu16.s; 100 Hz = 3640 ± 591 iu16.s; n = 5 from five
mice Figure 6A). These responses to nerve stimulation were
submaximal, because bath application of either 0.5 M potassium
chloride or 100 µM carbachol elicited calcium transients with
higher amplitudes (data not shown).
To examine calcium responses during fatigue, peak intensity
and the intensity at the end of stimulation (ending transient
intensity) were analyzed. In response to 30 s of 1 Hz nerve
stimulation, calcium transient intensity exhibited no significant
change in amplitude, similar to the effects of this stimulus on
EPPs, APs, tension, and shortening (peak intensity of 18.4 ± 4.4
SD iu16 vs. end intensity of 16 ± 3.8 SD iu16; P = 0.19; n = 5
from three mice; Figure 6A; Video 2). Although the temporal
dynamics of GCaMP3 preclude tracking all components of
individual transients at frequencies >6 Hz (Tian et al., 2009),
the overall change in intensity in response to high-frequency
trains can be measured. Similar to the fiber shortening studies,
transient intensity failed to decrease significantly in response
to 30 s of 10 or 20 Hz stimulation (10 Hz peak and ending
intensities were 76.3 ± 9.3 vs. 70.3 ± 10.3 SD iu16; P = 0.17;
20 Hz peak and ending intensities were 83.6 ± 19 vs. 64.2 ±
22.6 SD iu16; P = 0.051; n = 5 from three mice Figures 6A–D).
In contrast to 10 and 20 Hz nerve stimulation, 40 and 100
Hz caused a profound loss of transient intensity, similar to the
loss of peak length changes (40 Hz peak and ending intensities
were 88.2 ± 21.3 vs. 41.2 ± 14.6 SD iu16; P < 0.005; 100
Hz peak and ending intensities were 88.8 ± 10.5 vs. 8.2 ±
5.3 SD iu16; P < 0.001; n = 5 from three mice). The loss
of calcium transient intensity in response to 40 and 100 Hz
stimulation was also represented by spatio-temporal (ST) maps
of standard deviation, in which the change in intensity values
over time in a population of fibers is represented by differences
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FIGURE 6 | Calcium imaging studies in whole diaphragm show no fatigue in response to frequencies of nerve stimulation that show no neural
transmission failure. (A) Representative standard deviation (SD) of calcium intensity changes (16-bit intensity units; iu16) within BHC-treated muscle fibers from the
diaphragm of CAGGS-GCaMP3 mice in response to different frequencies of tonic nerve stimulation. (B) Spatio-temporal (ST) maps of the standard deviation (SD) of
intensity represent the loss of intensity over time as a signal that increases with nerve stimulation frequency. (C) Top image illustrates the region of the costal
diaphragm, the dotted lines surround a muscle fiber from which the intensity changes in (A) were generated. Boxed region shows population of muscle fibers whose
intensities signals were tracked over time for SD maps in (B) or intensity map subtractions in (lower three images in C). Lower images represent differential ST maps of
calcium intensity over time in response to different frequencies of nerve stimulation. In the 10/20 Hz comparison, the yellow signal from left to right indicates that the
10 and 20 Hz ST intensity maps (red, green) are equally maintained over the 30 s duration, whereas the red signal in the bottom two comparisons indicates a loss of
signal in the green 40 or 100 Hz ST intensity maps over time. (D) No significant loss of calcium signal is observed over time at frequencies that fail to induce NTF. (E)
Comparison of EPP rundown, AP transmission success rate, muscle force via tension or shortening, and calcium intensity, in response to 100 Hz nerve stimulation.
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of color intensity within them (Figure 6B). By superimposing
pseudo-colored ST maps of calcium transients at fatiguing
vs. non-fatiguing frequencies, both the spatial and temporal
characteristics of changes in calcium transient intensities could
be portrayed. For example, merged ST maps of 10 Hz (red)
and 20 Hz (green) stimulations appear predominantly yellow
throughout the 30 s period, representing similar intensities over
time throughout the recorded area of the diaphragm. Merged
ST maps of 10 Hz (red) and either 40 or 100 Hz (green) show
a change from yellow to red over time, with the loss of green
signal representing the loss of transient intensity in response
to these higher frequencies (Figure 6C). The loss of intensity
was not uniform throughout the diaphragm, with some regions
showing much earlier declines than other, often adjacent regions.
Interestingly, in response to fatiguing stimulation, the flashing of
individual muscle fibers could be observed (early portion of 100
Hz video, Video 2) consistent with the pattern of intermittent
failure observed with electrophysiological recordings. Together,
these results demonstrate the relationship between calcium
responses in adult muscle fibers and fatiguing nerve stimulation,
illustrating the utility of BHC for measuring calcium dynamics
within populations of the same fibers over time in ex vivo
neuromuscular preparations.
Evaluation of NTF and Fatigue in
Embryonic Wild-Type and Vamp2 Mutant
Mice
We tested whether BHC could permit the study of
neurotransmission and fatigue at E15.5, shortly after branches
of the phrenic nerve terminal navigate to and contact the
pre-patterned AChR cluster-enriched motor endplate. At these
stages, although the mRNA forµ-CTX-resistant Nav1.5 channels
predominates over µ-CTX-sensitive Nav1.4 channels (Lupa
et al., 1993; Wilson et al., 2011), the sodium currents underlying
embryonic muscle APs have not been examined. Therefore, we
investigated the effects of µ-CTX in E15.5 NMJs. Treatment
with any dose failed to prevent nerve-evoked muscle APs (data
not shown), consistent with a lack of functional Nav1.4 channel
expression. However, in the presence of BHC, nerve stimulation
produced measurable muscle APs (Figures 1B–F). The rise-time
of these APs was significantly longer than those from postnatal
muscle, consistent with the possibility that NMJs at these early
ages express slow, µ-CTX-resistant Nav1.5 channels (Wang
et al., 1996).
Embryonic Vamp2 mutant mice exhibit profoundly impaired
evoked release of neurotransmitter in the CNS and die shortly
after birth (Schoch et al., 2001). In order to identify the frequency
of nerve stimulation that was sufficient to produce fatigue in
embryonic muscle, the phrenic nerve of E15.5 WT mice was
tonically stimulated for 30 s at 1, 5, 10, and 20 Hz (Video 3),
and diaphragm muscle fiber length changes were measured
optically. Although 30 s of 1 Hz nerve stimulation failed to
produce fatigue, the inability to maintain peak fiber shortening
was observed toward the end of the 20 Hz stimulation period
(peak vs. ending length changes of 160.3 ± 25 vs. 91.5 ± 20.1
µm; 42% decline; P < 0.005; n = 4 from three mice; Figure 7A).
FIGURE 7 | Characterization of HFS in embryonic wild-type (WT) and
Vamp2 mutant mice. (A) Representative merged percent control traces of
fiber shortening in E15.5 WT mice. Note the progressive change in length
(shortening) of embryonic muscle fibers in response to increasing nerve
stimulation frequency. Note also the loss in maintenance of peak length
change in response to 20 Hz (green). (B) In contrast, HFS produces profoundly
less fiber shortening in E15.5 Vamp2 mutants. Images to the right of each
graph in (A,B) show the field of view from which data was obtained, including
the distance between the two contrasted regions (indicated by red, blue bars)
that were tracked in response to nerve stimulation. (C) Representative
recordings from the diaphragms of E15.5 WT (top trace) or Vamp2 mutant
(bottom trace) in the presence of BHC show that although nerve stimulation
can produce muscle APs in Vamp2 mutants, even low frequencies result in
NTF, illustrated by subthreshold muscle potentials (asterisk).
Fatigue was also examined in the diaphragms of E15.5 CAGGS-
GCaMP3 in the presence (data not shown) or absence of BHC.
Similar to fiber shortening, peak calcium fluorescence increased
proportionally with nerve stimulation frequency from 1 to 20 Hz
and fatigued in response to 20 Hz (Video 4). In contrast, E15.5
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Vamp2 mutant diaphragms exhibited a dramatically lower level
of fiber shortening in response to all frequencies (20 Hz peak
length change, Vamp2 mutant vs. WT; 16.8 ± 8 vs. 160.3 ± 25
µm; P < 0.001; n = 4 from three mice; Video 3; Figure 7B).
In order to determine whether these differences were related
to synaptic defects, nerve-evoked muscle APs were recorded
in E15.5 Vamp2 mutants in the presence of BHC. In response
to just several pulses of nerve stimulation at 1 Hz, Vamp2-
deficient muscle fibers exhibited NTF (n = 6 from three mice;
Figure 7C). This failure was not caused by neurodegeneration,
as motor neuron number and motor innervation of diaphragm
is exuberant at these stages (data not shown). These studies
show that the absence of Vamp2 severely impairs peripheral
neurotransmission during embryogenesis, and likely contributes
to the lethality that occurs shortly after birth. Taken together,
these data highlight some of the ways by which the skeletal
muscle myosin-specific blocker BHC can be applied to study
peripheral neurotransmission in both adult and embryonic mice.
DISCUSSION
These studies illustrate the utility of the skeletal muscle-
specific myosin ATPase inhibitor BHC, which paralyzes
muscle by impairing the function of the contractile apparatus
without affecting neurotransmission. In contrast, previously
identified skeletal muscle-specific myosin ATPase blockers
such as BTS impair neurotransmission. First, BHC permits the
electrophysiological characterization of muscle APs in ex vivo
intact muscle preparations and in response to nerve as well as
muscle stimulation. Second, BHC permits the measurement
of NTF in response to high frequencies of nerve or muscle
stimulation. We used this pharmacological tool to compare:
(i) the rundown of neurotransmitter release (reduced EPP
amplitudes), (ii) the extent of muscle fatigue, (iii) changes in
calcium dynamics in populations of muscle cells to the onset and
extent of NTF in mature and developing NMJs. We utilized this
property to show that Vamp2 mutant mice exhibit severe defects
in peripheral neurotransmission. Together, we expect that BHC
will be a profoundly useful tool for the study of neuromuscular
function during development, after injury, and in the context of
disease.
Individual nerve-evoked muscle APs recorded in the
presence of BHC from the mouse diaphragm exhibit similar
morphological attributes to previously published studies of rat
diaphragm muscle APs examined in individual muscle fibers in
response to direct muscle or nerve stimulation (Delbono and
Kotsias, 1987; van Lunteren and Moyer, 1998). Additionally,
the recording of muscle APs from transgenic mice expressing
GCaMP3 showed that they always correlated with the release
of calcium from intracellular stores (data not shown). These
results suggested that muscle APs could be measured in intact
muscle for the first time in response to HFS, which allows for
the empirical demonstration of NTF. We chose to perform an
ascending series of tonic phrenic nerve stimulation, since (1)
the diaphragm is driven by tonic or sustained stimuli during a
variety of conditions, as well as by phasic or cyclic stimulation
during respiration, and (2) tonic stimulation paradigms trigger
fatigue more quickly than phasic ones (Moyer and van Lunteren,
1999). We found that while adult diaphragm fibers never failed
to transduce neural into muscle APs in response to 30-s bouts
of stimulation at frequencies of 1–20 Hz, they exhibited NTF in
response to 40 and 100 Hz stimulation. When we correlated NTF
in the presence of BHC to synaptic depression in the presence
of µ-CTX, the onset of NTF coincided with the lowest safety
factor estimates (∼1.7; Wareham et al., 1994; Wood and Slater,
2001). For example, at 40 Hz, the onset of muscle AP failure
occurred between 25 and 27 s, and the onset of EPP amplitude
reduction below 1.7-fold occurred at 26–27 s. In response to
higher rates of HFS (e.g., 100 Hz), more pronounced percentage
rates of muscle AP failure occurred in parallel with more severe
drops of EPP amplitude, suggesting that higher safety factor
estimates represent concomitantly higher levels of impaired
neurotransmission.
Interestingly, we found that NTF occurred in intermittent
fashion, with failed APs followed by successful ones. This
dynamic nature of muscle AP failure was also confirmed in
calcium imaging of transgenic mice, in which fatiguing levels
of nerve stimulation produced intermittent flashing of calcium
transients (see the 100 Hz video in Video 2; end of 10 and 20 Hz
videos in Video 4). Despite this intermittent nature, the percent
of successfully transmitted muscle APs gradually fell over time in
response to 100 Hz. This decline roughly paralleled the synaptic
rundown of ACh observed in the presence of µ-CTX, suggesting
an underlying role for the reduction of neurotransmitter release
in this phenomenon. However, the “every-other” pattern of
muscle AP failure observed from seconds 2 to 5 after 100
Hz stimulation appears to involve other mechanisms, since
subsequent recordings from the same cells, in the presence of µ-
CTX, showed no such pattern of neurotransmitter release. One
possibility is the sensitivity of AChRs, which could be explored
by comparing mEPP amplitudes before and immediately after
the first few seconds of 100 Hz stimulation. Alternatively, the
postsynaptic gating kinetics of Nav1.4 channels might underlie
this unique intermittent pattern of muscle AP failure. While
the rate of fast inactivation is unlikely to be changed, since the
temporal parameters of muscle APs during this period of 50%
failure are similar in magnitude to muscle APs produced by other
lower-frequency trains in which there is 100% fidelity (data not
shown), the recovery from inactivation, or the deactivation, of
these channels may be regulated by HFS, since each of these
processes occur within ms (George, 2005). We also observed
several subpopulations of muscle fibers based on time to failure
in response to 100 Hz. The relative frequencies of these subtypes
were correlated to those expressing different MHC isoforms and
reflecting different fatigue properties. Finally, in addition to the
effects of BHC onmuscle predominantly composed of fast-twitch
fibers, we observed that BHC was also effective in suppressing
contractions in skeletal muscle predominantly composed of slow-
twitch fibers as well as cardiac muscle, but not smooth muscle
(Methods in Supplementary Material).
We next utilized the empirically observed time to NTF to
determine its contribution to muscle fatigue. In both tension
and optically-measured muscle fiber shortening methods, NTF
and fatigue were not observed in response to 30 s of 1 Hz nerve
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stimulation, consistent with early reports showing an absence
of fatigue in response to low-frequency stimulation (Aldrich
and Appel, 1985). At higher rates (40 and 100 Hz), there
was a proportional relationship between the rate of NTF and
decaying muscle responses, consistent with a number of reports
providing indirect evidence for a role of NTF inmediating fatigue
(reviewed in Sieck et al., 2013). We were intrigued, however,
by the finding in diaphragm strips that a loss of tension was
produced in response to 10 and 20 Hz stimulation, despite the
fact these frequencies failed to cause NTF. However, when we
repeated these experiments by measuring fiber shortening in
whole diaphragm, we failed to reproduce these results, although
there was a non-significant trend for 20 Hz nerve stimulation
to cause fatigue, as well as a loss of calcium transient intensity,
near the end of the 30-s nerve stimulation period. Thus, in
the absence of NTF, at stimulation frequencies between 1 and
20 Hz, muscle fatigue was not produced in whole diaphragm.
The discrepancy in results between these two measurements of
muscle force could arise from differences in force maintenance
between whole vs. strips of diaphragm, or because of the methods
used (tension vs. shortening). We favor the former, based on
the finding that tension in thin muscle strips results exclusively
from forces longitudinal or parallel to each muscle fiber, whereas
tension in intact diaphragm is mediated by transverse as well as
longitudinal forces (Margulies et al., 1994). The presence of such
biaxial forces may accordingly result in a reduced rate of fatigue.
Additionally, minor manipulations of muscle length dramatically
affect muscle tension and may similarly affect fatigue. Such
potential variability in resting length between different fiber strips
is less likely to occur in whole diaphragm, in which the entire
muscle maintains its insertions into the ribcage and central
tendon. Finally, although the phrenic nerve is cut proximally
in both muscle strips and whole diaphragm, its branches are
also cut in strip preparation, whereas all branches maintain
terminal innervation in whole diaphragm. Because motor axons
innervating an individual strip are likely part of motor units that
also innervate regions which are removed, it is possible that such
a preparation impairs the firing rate ofmotor neurons in response
to prolonged HFS.
The immobilization of muscle by BHC provided an
opportunity to explore calcium dynamics in muscle, which are
altered during muscle fatigue. We took advantage of transgenic
mice expressing GCaMP3 in muscle. Although the CAGGS
promoter in these mice, composed of CMV and chick β-
actin DNA elements, was expected to drive expression in all
cell types, we noted that activity-mediated fluorescence in the
neuromuscular system was largely restricted to skeletal muscle
fibers (data not shown). These responses were also observed in
mice expressing conditional GCaMP3 under control of theMyf5-
Cre driver, and were not observed in mice expressing GCaMP3
under control of Islet1-Cre or Wnt1-Cre drivers (which drive
expression in motor neurons and Schwann cells, respectively;
data not shown). Together with the use of BHC, GCaMP3
offers several features that facilitate calcium imaging in intact
muscle, including the capacity to be expressed by specific cell
types. On the other hand, GCaMP3 exhibits several shortcomings
when compared to ratiometric chemical calcium indicators or
calcium-selective microelectrodes, such as its inability to estimate
quantitative calcium concentrations (see however Albantakis and
Lohmann, 2009). Additionally, the low equilibrium dissociation
constant (KD) of GCaMP3 (287 nM) for calcium makes this
molecule unsuitable for the measurement of fast calcium events
such as the rate of calcium release. Although GCaMP3 can
only reliably represent entire transients up to 6 Hz, based on
limitations in the speed of rise and decay times within this sensor
(Tian et al., 2009), newer variants such as GCaMP6f exhibit
resolvable changes in calcium fluorescence at higher frequencies
(Chen et al., 2013). For the present study, only the magnitude
and maintenance of peak transient amplitudes of were required
to determine the effect of fatiguing nerve stimulation. We found
that similar to fiber shortening, 1–20 Hz nerve stimulation failed
to produce significant changes in calcium transient intensity in
muscle, whereas NTF-causing frequencies produced a loss of
signal similar to (40 Hz) or more pronounced than (100 Hz; see
Figure 6E) the loss of force caused by these stimuli.
Lastly, the use of BHC allows for the first time the
measurement of synaptic transmission in embryonic mice,
which are insensitive to Nav1.4 antagonists (Lupa et al., 1993;
Wilson et al., 2011). Although the use of bathing solutions with
low calcium allows nerve stimulation to produce subthreshold
transients that can be compared between different samples
(data not shown), the effect on presynaptic function of low
calcium precludes the analysis of presynaptic function on
neural transmission. Subparalytic doses of curare can also
produce subthreshold endplate potentials that can be recorded
electrophysiologically at the embryonic NMJ, but the presence
of off-target effects on presynaptic terminals (Glavinovic´, 1979),
coupled with the difficulty in generating reliable effects, make
this perturbation unfavorable. In any case, each of these
manipulations measures neural transmission at the embryonic
NMJ only by the subthreshold EPP, whereas BHC allows for
the study of muscle APs and subsequent calcium dynamics in
response to single nerve stimuli or HFS. In order to demonstrate
the nerve stimulation frequency that was sufficient to induce
fatigue, the optical measurement of shortening was applied, as
conventional tension transducing equipment is excessively large
for embryonic diaphragm fibers. Using this optical technique,
we were able to establish that 30 s of 20 Hz nerve stimulation
produced a profound fatigue or inability to maintain maximal
muscle fiber shortening in E15.5 diaphragm. Calcium imaging
of diaphragms from CAGGS-GCaMP3 mice replicated these
findings and also provided evidence that fatiguing muscle
fibers rebound before ultimately failing completely. Finally, we
provide evidence that nerve stimulation in Vamp2 mutants
can produce individual muscle APs, but leads to NTF almost
immediately at frequencies as low as 1 Hz. Taken together,
these studies suggest that BHC represents a powerful new tool
for measuring multiple aspects of neuromuscular function in
adult and embryonic mice, such as the correlation between
neurotransmitter release and neurotransmission success rate, the
correlation between neurotransmission success rate and muscle
tension, and the correlation between muscle calcium handling
and muscle tension, in a wide variety of mouse models of
neuromuscular dysfunction and/or disease.
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Supplementary Figure 1 | BTS blocks muscle movement but also disrupts
neurotransmission in the adult mouse diaphragm. Fifty µM of BTS was
added to hemidiaphragm preparations and muscle potentials were recorded in
response to 1 Hz phrenic nerve stimulation with sharp intracellular electrodes.
Recorded muscle potentials failed to exceed several mV.
Video 1 | Nerve stimulation at frequencies that fail to cause NTF in the
adult fail to cause fatigue. Thirty-second brightfield videos of tonic phrenic
nerve stimulation of adult diaphragm at 1, 10, 20, 40, and 100 Hz. Note
development of tetanic contraction over time in response to 10 Hz.
Video 2 | Nerve stimulation at frequencies that fail to cause NTF in the
adult fail to cause a loss of calcium transient intensity. Thirty-second
fluorescence videos of tonic phrenic nerve stimulation of adult diaphragm at 1, 10,
20 40, and 100 Hz. Note flashing of individual fibers during first half of 100 Hz
stimulation, representing intermittent neurotransmission.
Video 3 | Development of fatigue in response to high-frequency nerve
stimulation (HFS) in embryonic WT and Vamp2 mutant diaphragm.
Thirty-second fluorescence videos of tonic phrenic nerve stimulation of the left
side of E15.5 diaphragm at 1, 5, 10, and 20 Hz in WT (top panels) and Vamp2
mutant (bottom panels) mice. Note the failure in WT diaphragm to maintain peak
shortening in response to 20 Hz stimulation. Note also the failure of Vamp2 mutant
diaphragm to maintain the response to even 1 hz stimulation.
Video 4 | Development of fatigue in response to HFS in embryonic WT
diaphragm expressing GCaMP3. E15.5 CAGGS-GCaMP3 mice were
stimulated in the absence of BHC to illustrate the concordance of fiber shortening
and calcium transient intensity. Note the progressive loss in maintenance of peak
calcium transient intensity in response to increasing nerve stimulation frequency.
Note also that despite the ability of diaphragm to maintain peak or near-peak
shortening in response to 10 Hz for the entire 30-s period, an undulating pattern
of intermittent fluorescence occurs toward the end of stimulation, which appears
to presage fatigue, because this pattern of fluorescence occurs earlier and more
profoundly in response to 20 Hz stimulation. Finally, note the “spontaneous”
activation of bands of muscle fibers in all conditions before nerve stimulation, likely
representing the spontaneous release of transmitter that occurs in response for
several hours after nerve severance.
Methods: Effects of BHC on Slow-Twitch
Skeletal and Cardiac Muscle
Based on the heterogeneous nature of fiber subtype in the
diaphragm, together with the observation that movement is
suppressed within all muscle cells of the diaphragm in response
to BHC, that seems to be no predilection of this drug for fast
vs. slow muscle fibers. Moreover, muscle cells with different
failure rates in response to 100 Hz stimulation were recorded
from, suggesting that muscle cells expressing different MHC
isoforms are all sensitive to BHC. To further examine this feature,
the soleus was dissected and the nerve stimulated by suction
electrode before and after 30 min of 50 µM BHC treatment
and 30 min of perfused Krebs-Ringer’s solution (washout). By
visual observation, contractions in the majority of the soleus
were blocked, but a small region on the lateral half still exhibited
movement. After a further incubation with 100 µM BHC for
30 min and washout for 30 min, all movement of the soleus
desisted. Control soleus muscles still exhibited twitch in response
to nerve stimulation after a comparable time. Current studies are
investigating whether the region that remained after the first dose
were enriched in slow fibers, as the mouse soleus is composed
only of∼40% slow-twitch fibers (Wigston and English, 1992).
In order to examine the effects on the heart, the left ventricle
was dissected and the papillary muscles were exposed. In
response to electrical field stimulation (EFS), contractions could
be obtained for several hours. After 30 min of 50 µM BHC
treatment and washout, this EFS-induced twitch disappeared,
whereas in control papillary muscle, it persisted. These results
suggest that BHC, in contrast to BTS, suppresses contraction in
cardiac muscle and slow-twitch skeletal muscle, as well as fast-
twitch skeletal muscle. However, when strips of circular smooth
muscle-containing large intestine were induced to contract via
mucosal stimulation, 50–100 µM BHC failed to suppress these
movements.
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